Smooth IRT (IVR/IWR) Vendor Transition Guide
Source: Cenduit LLC
Pharmaceutical and biotech companies are increasingly reliant on their CROs (contract research organizations) and vendor partners to provide innovative, cutting edge solutions that will help them bring new therapies to market faster. According to a recent market research report1, the global clinical development outsourcing market will reach more than $64 billion by 2020, with CROs managing close to 72% of all clinical trials. As sponsors continue to adopt the outsourced model, sponsor-vendor relationships will play a pivotal role in the success of the clinical trial.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more